MediciNova Inc (MNOV)
1.31
-0.07
(-5.07%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
MediciNova Free Cash Flow: -7.452M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.452M |
| September 30, 2023 | -10.96M |
| June 30, 2023 | -12.31M |
| March 31, 2023 | -12.36M |
| December 31, 2022 | -12.91M |
| September 30, 2022 | -12.54M |
| June 30, 2022 | -12.84M |
| March 31, 2022 | -9.285M |
| December 31, 2021 | -9.410M |
| September 30, 2021 | -7.753M |
| June 30, 2021 | -8.644M |
| March 31, 2021 | -11.84M |
| December 31, 2020 | -10.86M |
| September 30, 2020 | -11.29M |
| June 30, 2020 | -9.422M |
| March 31, 2020 | -8.986M |
| December 31, 2019 | -9.136M |
| September 30, 2019 | -8.368M |
| June 30, 2019 | -8.065M |
| March 31, 2019 | -8.066M |
| December 31, 2018 | -9.124M |
| September 30, 2018 | -8.526M |
| June 30, 2018 | -8.710M |
| March 31, 2018 | -8.467M |
| December 31, 2017 | -6.924M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.954M |
| June 30, 2017 | -6.651M |
| March 31, 2017 | -6.737M |
| December 31, 2016 | -6.631M |
| September 30, 2016 | -7.071M |
| June 30, 2016 | -6.627M |
| March 31, 2016 | -6.362M |
| December 31, 2015 | -7.155M |
| September 30, 2015 | -6.671M |
| June 30, 2015 | -7.090M |
| March 31, 2015 | -7.185M |
| December 31, 2014 | 0.813M |
| September 30, 2014 | -2.188M |
| June 30, 2014 | -2.488M |
| March 31, 2014 | -3.301M |
| December 31, 2013 | -10.69M |
| September 30, 2013 | -8.841M |
| June 30, 2013 | -9.391M |
| March 31, 2013 | -11.13M |
| December 31, 2012 | -11.95M |
| September 30, 2012 | -10.71M |
| June 30, 2012 | -11.24M |
| March 31, 2012 | -12.78M |
| December 31, 2011 | -13.31M |
| September 30, 2011 | -15.99M |
Free Cash Flow Range, Past 5 Years
-12.91M
Minimum
Dec 2022
-7.452M
Maximum
Dec 2023
-10.23M
Average
-9.422M
Median
Jun 2020
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.4991M |
| Free Cash Flow Per Share (Quarterly) | -0.0102 |
| Free Cash Flow Yield | -11.60% |